Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ASTON/Montag & Caldwell Growth Fund Class N (MCGFX)

27.38
Net Asset Value
-0.04%
1 Day
+8.31%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
1.04%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation and, secondly, current income. The fund invests primarily in common stocks, convertible preferred stocks, and convertible bonds. The subadviser uses a bottom-up approach to stock selection and seeks high quality, well-established, large-cap companies that the subadviser believes are growing their near-term earnings at an above average rate. The managers define a large-cap company as one having a market capitalization of $5 billion or more at the time of acquisition. It may invest in foreign securities (directly and through depositary receipts).

Performance

1 month+4.58% 3 years+14.67%
3 months+7.41% 5 years+14.32%
1 year+12.48% Since inception+9.25%
Data through --

Peer Comparisonvs. Large growth

 MCGFXCategory
Performance 5-yr return+14.32%+16.96%
Expense ratio1.04%1.20%
Risk 5 year sharpe ratio1.341.23
Net assets$2.3B$2.7B
Average market cap$74.3B$76.4B
Average P/E25.421.4
Portfolio turnover47%47%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAston
Fund manager & tenureRonald Canakaris / 20 Years
Minimal initial investment$2,500.00
Minimum IRA investment$500.00

Holdings

U.S. stock90.27%
Cash5.33%
International stock4.40%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 20.99%
Energy 16.69%
Consumer service 11.42%
Healthcare 11.31%
Telecommunication 9.37%
Top 10 Holdings
Portfolio weighting
AGN Allergan4.40%
PEP Pepsi4.34%
MDLZ Mondelez International Inc4.32%
V Visa4.24%
MCK McKesson Corp4.02%
ABT Abbott Laboratories3.60%
GILD Gilead Sciences3.51%
SBUX Starbucks3.35%
TMO Thermo Fisher Scientific Inc3.30%
BIIB Biogen3.23%